Skip to main content
. 2015 Nov 29;7:88–96. doi: 10.1016/j.redox.2015.11.012

Fig. 2.

Fig. 2

ATRA modulated DCFH2 oxidation and MitoSOX oxidation in SK-N-SH cells. MitoSOX (n=5) and DCF (n=4) fluorescence of SK-N-SH cells after treatment with ATRA (10 μM) for 24, 48, 72, and 96 h. MitoSOX: *p<0.05 vs. CON. DCF: p<0.05 vs. CON. T-test performed for each time point vs. CON. Results are expressed as fold changes vs. CON at each time point±SEM.